Our lab and others have also shown in previous studies an activation of phospholipase D2 (PLD2) through EGFR in cancer cells6, 7, 8, 9, 10 however, no long-term studies of PA on the receptor have yet been documented. This evidence concerns the gene PLD2 and cancer.